首页> 外文期刊>Bone marrow transplantation >A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
【24h】

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.

机译:在常规或非清髓性条件处理以及来自人白细胞抗原相同同胞供体的骨髓或外周血干细胞移植后,T,B和NK细胞重构的比较。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts from their HLA-identical sibling donors. In all, 15 patients received PBSC after a nonmyeloablative conditioning regimen consisting of fludarabine and 200 cGy TBI, 13 patients received PBSC after myeloablative conditioning and 37 patients received BM after myeloablative conditioning. In the nonmyeloablative group, the NK cells normalised after 1 month, the CD8+ T cells normalised after 3 months, the CD4+ T cells reached near normal values after 9 months and the B cell values were reduced until 12 months after transplant. In the two myeloablative groups, recipients of PBSC had a significantly higher number of CD4+ T cells after 4 months (P=0.004) and after 12 months (P=0.001), than recipients of BM. We found no differences in the T cell reconstitution between the two PBSC groups. This was of interest as the recipients of nonmyeloablative conditioning were older (P<0.001) and had a higher occurrence of chronic GVHD (P<0.05) than the recipients of myeloablative conditioning. In contrast, the recipients of nonmyeloablative conditioning had a delayed B cell recovery when compared to the patients who received myeloablative conditioning (P=0.04).
机译:这项回顾性研究比较了三组患者的T,B和NK细胞在血液学恶性肿瘤中的移植情况,这些患者接受了来自其HLA同胞捐赠者的移植物。共有15例患者接受了氟达拉滨和200 cGy TBI的非清髓性调理方案后接受PBSC,13例患者在清髓性调理后接受了PBSC,37例进行了清髓性调理后接受了BM。在非清髓性治疗组中,NK细胞在1个月后恢复正常,CD8 + T细胞在3个月后恢复正常,CD4 + T细胞在9个月后达到接近正常值,B细胞值降低直至移植后12个月。在两个清髓性治疗组中,PBSC的接受者在4个月(P = 0.004)和12个月(P = 0.001)之后的CD4 + T细胞数量明显高于BM。我们发现两个PBSC组之间的T细胞重构没有差异。这是令人感兴趣的,因为非清髓性调理的接受者比清髓性调理的接受者年龄更大(P <0.001),并且慢性GVHD的发生率更高(P <0.05)。相反,与接受清髓治疗的患者相比,非清髓治疗的接受者的B细胞恢复延迟(P = 0.04)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号